Information:
Fel:
ID
25951
Beskrivning
Investigators Statement Ropinirole Case Report Form GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Nyckelord
Versioner (1)
- 2017-10-01 2017-10-01 -
Rättsinnehavare
gsk
Uppladdad den
1 oktober 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Similar models
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
INVESTIGATOR’S STATEMENT
C1710187 (UMLS CUI-1)
C2826892 (UMLS CUI-2)
C2826892 (UMLS CUI-2)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
completion
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C0805732 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
consent
Item
I certify to the best of my knowledge, that the observations and findings are recorded correctly and completely in this CRF.
boolean
C1511481 (UMLS CUI [1])
Investigator
Item
Investigator
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])